Health Canada inspection
Pfizer Inc.: Health Canada inspection of Sep 28, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Pfizer Inc. |
|---|---|
| City | Parsippany |
| Province | NJ |
| Country | United States |
| Program | GMP |
| Start date | Sep 26, 2022 |
| End date | Sep 28, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | Not applicable |
At a glance
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.